In clinical research, the statistical analysis acts as the definitive bridge between raw clinical data and scientific conclusions. The integrity of this process is fundamental; even minor errors in programming or deviations from the predefined Statistical Analysis Plan (SAP) can lead to invalid results, potentially jeopardizing years of research and significant investment. A statistical analysis audit is an independent, rigorous evaluation of the methodology, programming, and outputs to ensure that the final study results are accurate, reproducible, and fully compliant with regulatory standards.
Protheragen provides audit services of statistical analysis for clinical research projects. Our audit acts as a vital quality assurance mechanism. By objectively reviewing the statistical lifecycle of a study, we assist sponsors and research organizations in identifying systematic anomalies, correcting programming inaccuracies, and ensuring that the final statistical outputs are robust, reproducible, and ready for regulatory submission.
Protheragen offers comprehensive audit support for statistical analysis activities conducted during clinical development. Our services focus on reviewing analytical processes, documentation quality, statistical programming controls, and compliance-related considerations associated with clinical trial data analysis.
Assessment of statistical analysis plans for consistency with study protocols, endpoint definitions, analysis populations, and predefined analytical methodologies.
Review of statistical programming practices, code validation procedures, quality control workflows, and programming documentation associated with clinical trial analyses.
Evaluation of dataset preparation procedures, derivation rules, variable definitions, and traceability between raw data and analysis datasets.
Review of randomization methodologies, treatment allocation procedures, and controls supporting maintenance of study blinding where applicable.
Assessment of statistical models, hypothesis testing strategies, handling of missing data, interim analyses, and multiplicity control approaches.
Examination of tables, listings, figures, and statistical outputs for consistency with source datasets, analysis plans, and clinical study reports.
Review of documentation practices, version control procedures, audit trails, and compliance with applicable regulatory and GCP expectations.
Assessment of third-party statistical service providers, oversight procedures, communication workflows, and quality management controls.
Clinical trial conclusions rely heavily on the accuracy and appropriateness of statistical analyses. Structured audits of statistical activities can support transparency, reproducibility, and operational consistency throughout the analysis process. Statistical analysis audits may help organizations:
Evaluate the consistency of analytical procedures
Support traceability between raw data and reported results
Identify process gaps and documentation inconsistencies
Assess compliance with predefined analysis plans
Strengthen oversight of outsourced statistical activities
Improve quality management procedures for data analysis
Support regulatory inspection readiness
Regulatory agencies increasingly emphasize data integrity, reproducibility, and documentation quality in clinical research. Comprehensive oversight of statistical analysis activities is therefore an important aspect of modern clinical quality systems.
Our biostatistical experts provide objective, third-party oversight to identify compliance gaps and ensure your results are inspection-ready. If you would like to learn more about statistical analysis audit services, please feel free to contact us.
1. Can the audit focus on a specific part of the statistical analysis, such as the primary endpoint?
Yes, the audit scope can be tailored to concentrate on critical elements, such as the primary efficacy analysis, safety summaries, or a particular population. A focused audit is useful when resources are limited or when a previous inspection finding needs to be addressed, while a full-scope audit provides the most comprehensive assurance.
2. How is the confidentiality of patient-level data and proprietary statistical programs ensured during the audit?
The audit is conducted under strict confidentiality agreements and secure data-handling protocols. Data are reviewed within a controlled environment, access is limited to authorized auditors, and all files are securely destroyed or returned after the audit. Non-disclosure provisions cover both patient data and proprietary programming code.
3. What qualifications do the auditors have?
Auditors are experienced statisticians or statistical programmers with in-depth knowledge of clinical trial design, CDISC standards, ICH guidelines, and regulatory submission requirements. They have practical experience across multiple therapeutic areas and are trained in GCP audit methodology and relevant software environments.
4. What happens if critical findings are identified during the audit?
Critical findings are communicated promptly to the sponsor's management. A corrective and preventive action (CAPA) plan is developed to address the root cause. The audit team may perform a follow-up review to verify that corrections have been implemented and that re-analysis, if required, is correctly performed before any regulatory submission.